GWA
AGN

Genesis Wealth Advisors’s Allergan plc AGN Stock Holding History

Genesis Wealth Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$6.37K Buy
+21
New +$6.26K 0.01% 388

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Genesis Wealth Advisors's AGN Position: Q2 2015 in Review

Genesis Wealth Advisors opened a new position in Allergan plc (AGN) in Q2 2015: 21 shares worth $6.37K. The stake represents 0.01% of the portfolio and ranks #388 among its holdings.

1,035 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Genesis Wealth Advisors held 21 shares of Allergan plc worth $6.37K as of Q2 2015.
  • Allergan plc was a new Genesis Wealth Advisors position in Q2 2015.
  • Allergan plc made up 0.01% of Genesis Wealth Advisors's portfolio in Q2 2015, its #388 holding.
  • 1,035 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Genesis Wealth Advisors's 13F filing for Q2 2015, filed 24 Aug 2015.